{"id":61456,"date":"2024-02-28T07:41:49","date_gmt":"2024-02-28T07:41:49","guid":{"rendered":"https:\/\/medsname.com\/d-mine\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"d-mine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/d-mine\/","title":{"rendered":"D-mine"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is D-mine?<\/h3>\n<div style=\"margin:0;\">\n<p style=\"margin:0;\"><strong>D-mine<\/strong> bevat <strong>imipramine 25 mg<\/strong> from a WHO-GMP certified manufacturer (Sun Pharma) &mdash; the <strong>original tricyclic antidepressant<\/strong>, in continuous clinical use since 1959. Tertiary-amine TCA: serotonin and norepinephrine reuptake inhibition plus muscarinic, histamine H<sub>1<\/sub>, and alpha-1 antagonism (the source of side effects). Largely displaced by SSRIs for first-line depression but still used for: <strong>paniekstoornis<\/strong> (one of the most-evidenced TCAs for this), <strong>chronic neuropathic pain<\/strong> at low doses, and <strong>paediatric nocturnal enuresis<\/strong> (bedwetting) where it has FDA approval. <strong>Cardiac toxicity in overdose<\/strong> &mdash; baseline ECG before starting. Strong anticholinergic burden &mdash; not first-line in older adults.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Wat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Elke bestelling is gedekt door onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n<h3>Waarom bestellen bij MedsBase<\/h3>\n<p>Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 22px 0;border-radius:4px;font-size:14px;\"><strong>Belangrijk \u2014 dit is geen medicijn voor situationele angst.<\/strong> D-mine is a <strong>tricyclic antidepressant (TCA)<\/strong>, geneesmiddel dat wekenlang wordt voorgeschreven en getitreerd voor <strong>major depressive disorder (MDD), panic disorder, paediatric nocturnal enuresis, and chronic pain syndromes<\/strong>. Het is <strong>niet<\/strong> niet het juiste medicijn voor acute, prestatiegerelateerde angst (vliegen, spreken in het openbaar, examens) \u2014 voor die gevallen zijn b\u00e8tablokkers (propranolol), benzodiazepinen of hydroxyzine klinisch geschikter. Als u geen gediagnosticeerde stemmings-, angst- of psychiatrische stoornis heeft, begin dan niet met dit medicijn.<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 22px 0;border-radius:4px;font-size:14px;\"><strong>FDA black-box waarschuwing \u2014 su\u00efcidaliteit.<\/strong> Alle antidepressiva dragen een FDA black-box waarschuwing voor een verhoogd risico op su\u00efcidale gedachten en gedrag bij kinderen, adolescenten en jongvolwassenen onder de 25 jaar, met name tijdens de eerste weken van de behandeling of na doseringsaanpassingen. Familieleden en voorschrijvers moeten in deze leeftijdsgroep goed letten op verslechterende stemming, agitatie of su\u00efcidale ideatie.<\/div>\n<h2 class=\"wp-block-heading\">What Is D-mine?<\/h2>\n<p>D-mine is an oral tablet of <strong>imipramine hydrochloride 25 mg<\/strong> manufactured by Sun Pharma. Imipramine (US brand <strong>Tofranil<\/strong>) was synthesised in 1948 and identified as the first effective antidepressant in 1957 &mdash; the foundation of modern psychopharmacology. It is a <strong>tertiary-amine tricyclic antidepressant<\/strong> that inhibits serotonin and norepinephrine reuptake while also blocking muscarinic, histamine H<sub>1<\/sub>, and alpha-1 receptors. The serotonergic \/ noradrenergic actions drive efficacy; receptor blockade drives most of the side-effect burden.<\/p>\n<h2 class=\"wp-block-heading\">Goedgekeurde indicaties<\/h2>\n<ul>\n<li><strong>Major depressieve stoornis<\/strong> &mdash; second- or third-line after SSRIs \/ SNRIs<\/li>\n<li><strong>Paniekstoornis<\/strong> &mdash; one of the most-evidenced TCAs; effective but better tolerated alternatives exist<\/li>\n<li><strong>Childhood nocturnal enuresis (bedwetting)<\/strong> &mdash; FDA-approved for ages 6+ when behavioural therapy and desmopressin have failed<\/li>\n<li>Off-label: chronic neuropathic pain, fibromyalgia, post-herpetic neuralgia, chronic low back pain<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Dosering<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:0 0 22px 0;font-size:14px;\">\n<thead>\n<tr>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px 10px;border:1px solid #2c7cb0;text-align:left;\">Indicatie<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px 10px;border:1px solid #2c7cb0;text-align:left;\">Start<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px 10px;border:1px solid #2c7cb0;text-align:left;\">Streefdosering<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px 10px;border:1px solid #2c7cb0;text-align:left;\">Opmerkingen<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#ffffff;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">MDD (adult outpatient)<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">25&ndash;75 mg\/day at bedtime<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">100\u2013200 mg\/dag<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Maximum 200 mg\/day outpatient; up to 300 mg\/day inpatient; titrate over 2&ndash;4 weeks<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">MDD (elderly)<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">10&ndash;25 mg at bedtime<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">25&ndash;100 mg\/day<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Lower target; greater anticholinergic and orthostatic risk<\/td>\n<\/tr>\n<tr style=\"background:#ffffff;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Paniekstoornis<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">10&ndash;25 mg at bedtime &times; 1 week<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">75&ndash;200 mg\/day<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Langzame op-titratie om vroege verergering van paniek te voorkomen<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Childhood enuresis (age 6&ndash;12)<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">25 mg one hour before bedtime<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">25&ndash;50 mg one hour before bedtime<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Maximum 2.5 mg\/kg\/day; reassess after 3 months &mdash; relapse common on stopping<\/td>\n<\/tr>\n<tr style=\"background:#ffffff;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Childhood enuresis (age 12+)<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">25 mg one hour before bedtime<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">25&ndash;75 mg one hour before bedtime<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Maximum 75 mg\/day; same reassessment<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Side Effects (Anticholinergic Burden Is the Main Issue)<\/h2>\n<h2 class=\"wp-block-heading\">Bijwerkingsprofiel per werkingsmechanisme<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:0 0 22px 0;font-size:14px;\">\n<thead>\n<tr>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px 10px;border:1px solid #2c7cb0;text-align:left;\">Werkingsmechanisme<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px 10px;border:1px solid #2c7cb0;text-align:left;\">Effecten<\/th>\n<th style=\"background:#2c7cb0;color:#fff;padding:8px 10px;border:1px solid #2c7cb0;text-align:left;\">Opmerkingen<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#ffffff;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Anticholinergic (muscarinic blockade)<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Dry mouth, constipation, urinary retention, blurred vision, cognitive impairment<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Heavy &mdash; not first-line in older adults; caution with BPH, glaucoma, dementia<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">H<sub>1<\/sub> blokkade<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Sedation, weight gain<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Useful when insomnia is part of the depression; less useful daytime<\/td>\n<\/tr>\n<tr style=\"background:#ffffff;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Alpha-1-blokkade<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Orthostatic hypotension, dizziness, falls<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Particularly problematic in older adults; check lying \/ standing BP<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Cardiac (sodium-channel blockade)<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">QT and QRS prolongation, AV block<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Baseline ECG before starting in patients &gt; 50 or with cardiac history; deadly in overdose &mdash; do not provide bulk supplies to acute suicide-risk patients<\/td>\n<\/tr>\n<tr style=\"background:#ffffff;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Serotonergic \/ noradrenergic<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Sweating, tremor, sexual dysfunction<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Generally manageable<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Anders<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Lowered seizure threshold, paradoxical mania (in unrecognised bipolar)<\/td>\n<td style=\"padding:8px 10px;border:1px solid #ddd;vertical-align:top;\">Caution in epilepsy, screen for bipolar before starting<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Geneesmiddelinteracties<\/h2>\n<p><strong>Absolute contra-indicaties<\/strong>: MAOIs (14-day washout), recent myocardial infarction, severe uncontrolled cardiac disease.<\/p>\n<p><strong>Cardiaal risico<\/strong>: avoid concurrent QT-prolonging drugs (citalopram &gt; 20 mg, quetiapine, ziprasidone, ondansetron, methadone, fluoroquinolones).<\/p>\n<p><strong>CYP2D6-substraat<\/strong>: plasma levels rise with strong inhibitors (paroxetine, fluoxetine, bupropion, quinidine). Use lower doses.<\/p>\n<p><strong>Anticholinergic potentiation<\/strong>: combine cautiously with other anticholinergics (diphenhydramine, scopolamine, trihexyphenidyl, oxybutynin).<\/p>\n<p><strong>Sedation \/ orthostasis<\/strong>: alcohol, benzodiazepines, opioids, alpha-blockers.<\/p>\n<h2 class=\"wp-block-heading\">Cardiac Safety and Overdose Risk<\/h2>\n<p>TCAs are <strong>among the most lethal drugs in overdose<\/strong> because of cardiac sodium-channel blockade, which produces wide-complex tachycardia, ventricular arrhythmias, and cardiogenic shock at doses 5&ndash;10x therapeutic. <strong>Baseline ECG<\/strong> is standard practice before starting in patients over 50 or with cardiac risk factors. <strong>Provide only 1&ndash;2 weeks of medication at a time<\/strong> to patients at meaningful suicide risk &mdash; a 30-day supply of imipramine 25 mg is potentially lethal.<\/p>\n<h2 id=\"faqs\">Veelgestelde vragen<\/h2>\n<h3 class=\"wp-block-heading\">How long does D-mine take to work?<\/h3>\n<p>Mood response in MDD typically appears at 4&ndash;6 weeks. Panic disorder response at 4&ndash;8 weeks. Enuresis response in children is usually seen within 1&ndash;2 weeks of an effective dose.<\/p>\n<h3 class=\"wp-block-heading\">Is D-mine safer than amitriptyline?<\/h3>\n<p>Imipramine and amitriptyline have similar profiles. Nortriptyline (Primox on this site) and desipramine (secondary-amine TCAs) are usually better tolerated &mdash; less anticholinergic and less sedating &mdash; if a tricyclic is needed.<\/p>\n<h3 class=\"wp-block-heading\">Can children safely take D-mine for bedwetting?<\/h3>\n<p>Yes &mdash; imipramine has been used for paediatric nocturnal enuresis since the 1960s with FDA approval. Always third-line after behavioural \/ alarm therapy and desmopressin. Cardiac risk is low at standard enuresis doses but ECG should be checked if dose exceeds 75 mg\/day or if there is a family history of arrhythmia \/ sudden death.<\/p>\n<h3 class=\"wp-block-heading\">Why are TCAs no longer first-line for depression?<\/h3>\n<p>Side-effect burden (anticholinergic, sedation, orthostasis) and overdose lethality have shifted first-line treatment to SSRIs and SNRIs since the late 1980s. TCAs remain useful for refractory depression, neuropathic pain, and panic.<\/p>\n<h3 class=\"wp-block-heading\">Will D-mine cause weight gain?<\/h3>\n<p>Yes &mdash; TCAs cause significant weight gain (5&ndash;10 kg or more over months) through H<sub>1<\/sub> appetite stimulation. This is one of the main reasons patients switch to SSRIs.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol on D-mine?<\/h3>\n<p>Avoid heavy alcohol &mdash; additive sedation, orthostasis, and lowered seizure threshold. Light occasional alcohol is generally tolerated but caution is warranted.<\/p>\n<h3 class=\"wp-block-heading\">Wat gebeurt er als ik een dosis mis?<\/h3>\n<p>Take it as soon as you remember unless close to the next dose. Imipramine has a long half-life so missing one dose rarely causes withdrawal.<\/p>\n<h3 class=\"wp-block-heading\">Is D-mine safe in pregnancy?<\/h3>\n<p>Limited data &mdash; not first-line in pregnancy. SSRIs (sertraline preferred) have a far larger safety database. Late third-trimester exposure has been associated with neonatal withdrawal symptoms.<\/p>\n<h3 class=\"wp-block-heading\">Can D-mine be combined with other antidepressants?<\/h3>\n<p>Sometimes &mdash; low-dose TCAs are added to SSRIs in treatment-resistant depression but only under prescriber direction. Combining with MAOIs is contraindicated.<\/p>\n<h3 class=\"wp-block-heading\">How should D-mine be stored?<\/h3>\n<p>Store at 15&ndash;30 &deg;C in the original blister packaging away from moisture and sunlight. <strong>Keep strictly out of reach of children<\/strong> &mdash; TCA overdose is rapidly lethal.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:24px 0 0 0;border-radius:4px;font-size:13.5px;line-height:1.55;\"><strong>Medische disclaimer:<\/strong> De informatie op deze pagina is bedoeld voor volwassenen die voorgeschreven psychiatrische medicatie gebruiken en is geen vervanging voor individuele medische zorg. Antidepressiva, antipsychotica en aanverwante medicijnen kunnen interacteren met andere medicijnen, alcohol en bestaande aandoeningen. Bespreek elk nieuw medicijn, doseringswijziging of geplande stopzetting met een gekwalificeerde voorschrijver. Als u su\u00efcidale gedachten, manie, ernstige akathisie, tekenen van serotoninesyndroom (hoge koorts, verwardheid, spierstijfheid, snelle hartslag) of neuroleptisch maligne syndroom ervaart, zoek dan onmiddellijk spoedeisende hulp.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Gerelateerde alternatieven<\/h3>\n<p>Andere producten in <strong>Chronische aandoeningen<\/strong> die klanten ook bekijken:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nl\/olmezest-am\/\">Olmezest AM<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/minirin-nasal-spray\/\">Minirin Neusspray<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/indicid-75-sr\/\">Indicid-75 SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/aricep\/\">Aricep<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/atenheal\/\">Atenheal<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Alleviates depression symptoms<br \/>\n\u2705 Verbeterde stemmingstabiliteit<br \/>\n\u2705 Reduces anxiety levels<br \/>\n\u2705 Verbetering van de slaapkwaliteit<br \/>\n\u2705 Manages panic attacks<\/p>\n<p>D-mine contains Imipramine.<\/p>","protected":false},"featured_media":61457,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,4647],"product_tag":[5036,4333],"class_list":{"0":"post-61456","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-situational-anxiety-treatment","9":"product_tag-d-mine","10":"product_tag-imipramine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/61456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=61456"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/61457"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=61456"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=61456"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=61456"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=61456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}